Medicine by Design-funded TOGETHER network aims to make Ontario a hub for rare disease gene therapy

This blog post is just one of many in Signal’s seventh annual blog carnival discussing what hurdles need to be overcome for cell and gene therapies in clinical trials to reach the marketplace and whether the system is prepared.

By |2023-08-22T08:16:32-04:00August 22nd, 2023|Categories: News|Tags: , , |

Technology supported through Medicine by Design’s Grand Questions Program automates the study of cell behaviour to accelerate regenerative medicine treatments

New technology allows researchers to watch single cell behaviour at scale

By |2023-08-25T11:06:17-04:00July 10th, 2023|Categories: News, Research Publication|Tags: , , |

Medicine by Design funds high-performing students from underrepresented groups in second year of Summer Student Research Program

Program is a partnership with the Research Application Support Initiative at the Temerty Faculty of Medicine and funds the student positions at $10k each

By |2023-06-12T13:00:38-04:00June 12th, 2023|Categories: News|Tags: , |

Medicine by Design invests $1 million in Convergent Working Group projects to integrate new strands of inquiry and expand its community across sectors

Seven new projects will focus on equity, commercialization policy, new regenerative medicine applications and more

By |2023-09-14T16:17:26-04:00June 5th, 2023|Categories: Awards, News|Tags: , , |

Teams focused on cell therapy and diagnostics win first and second place at the Building a Biotech Venture Pitch Competition

Myoxa Therapeutics and Specifix Dx win the Building a Biotech Venture Pitch Competition

Go to Top